Elsevier Partners with the Royal Netherlands Society for Agricultural Sciences (KLV)
New partnership to publish NJAS - Wageningen Journal of Life Sciences
Amsterdam, 12 November 2008 - Elsevier, a leading publisher of scientific, technical and medical information products and services, announced today that it will publish NJAS - Wageningen Journal of Life Sciences on behalf of Royal Netherlands Society for Agricultural Sciences (KLV), starting in 2009 with Volume 57, issue 1.
NJAS - Wageningen Journal of Life Sciences, published since 1952, is the quarterly journal of the Royal Netherlands Society of Agricultural Sciences. It offers new research results of disciplinary as well as transdisciplinary and interdisciplinary studies, with an emphasis on interaction between natural and social sciences and system approaches in:
• Plant Science, Plant Genetics and Biotechnology
• Animal Science
• Environmental Science
• Social Science
• Food Science, Nutrition and Technology
Elsevier will distribute the NJAS globally via ScienceDirect, its market-leading electronic platform. ScienceDirect is currently accessed by over 11 million users worldwide who are able to easily further their research through linked references and many other helpful features.
Elsevier Publisher Gilles Jonker noted, "We are very honoured to publish this long standing journal, and hope that in doing so we will further strengthen our relationship with the Royal Netherlands Society of Agricultural Sciences”.
Prof. dr. ir. E.W. Brascamp, President of the KLV, added, “I am confident that the relation with Elsevier will further internationalize authorship, will highlight the interdisciplinary nature of the journal, and will help increase the visibility through exposure via ScienceDirect.”
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+31 20 485 2291